---
company: REGENERON PHARMACEUTICALS, INC.
ticker: REGN
form: 8-K
filed: 2026-10-06
accession: 0001104659-26-113895
source: https://www.sec.gov/Archives/edgar/data/872589/000110465926113895/
---

# Regeneron Pharmaceuticals (REGN) earnings release, October 6, 2026

Regeneron Pharmaceuticals, Inc. (REGN) · Form 8-K, Item 2.02 · Filed 2026-10-06 · [SEC filing](https://www.sec.gov/Archives/edgar/data/872589/000110465926113895/)

No press release attached to this 8-K.
